Evotec drives innovation in pain drug discovery through integrated neuroscience expertise, cutting-edge technologies, and translational platforms. Our comprehensive in vitro and in vivo capabilities - spanning high-throughput electrophysiology, advanced sensory neuron assays, and clinically relevant pain models - enable precise target validation and predictive translational outcomes. With over 100 dedicated neuroscience experts and 200+ validated CNS pharmacology models, Evotec provides end-to-end solutions that de-risk programs, accelerate timelines, and advance the development of novel pain therapeutics.